Bixiye
P17-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective July 2, 2018
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2018
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2991 - 3000 ee natiijooyinka 3289
Bixiye
P18-18 2018 Renewal Changes Summary For Aware Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2018
Bixiye
QP30-18 Subscriber Identification (ID) Cards
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 27, 2018
Bixiye
QP29-18 Pharmacy Benefit Update - Prior Authorization Requirement for Keveyis (dichlorphenamide)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 25, 2018
Bixiye
QP28-18 Vision Benefit Available on Availity
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 25, 2018
Bixiye
QP27-18 Post Service Claim Appeals
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 24, 2018
Bixiye
QP26-18 Predetermination Request Form for Commercial Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 19, 2018
Bixiye
QP25-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Samsca (tolvaptan)
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 19, 2018
Bixiye
QP23-18 Pharmacy Benefit Exclusion for Crysvita
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2018
Bixiye
QP24-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Multiple Sclerosis (MS) Agents
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 13, 2018